Acadia Pharma (ACAD) Misses Q1 EPS by 6c
Tweet
Share
E-mail
Get Alerts ACAD Hot Sheet
Price: $26.41 +1.58%
Revenue Growth %: +11.8%
Financial Fact:
Net loss: -71.61M
Today's EPS Names:
CCEL, SLP, TMQ, More
Revenue Growth %: +11.8%
Financial Fact:
Net loss: -71.61M
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q1 EPS of ($0.27), $0.06 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $118.46 million versus the consensus estimate of $119.99 million.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Key things to know ahead of SK Hynix’s blockbuster US listing
- ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half
- Northern Technologies (NTIC) Misses Q3 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
